Analysts: Aetna to Meet Targets and 3 New Opinions Investors Must Know Now

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Cree Inc. (NASDAQ:CREE): According to Sterne Agee, Cree has tailwinds for further gross margin improvements that have not been adequately reflected in consensus estimates. The firm has decided to keep its Buy rating but raised its price target to $64 from $48 on the stock.

The stock market is roaring back in 2013. Click here now to discover winning stocks!


More Articles About:

To contact the reporter on this story: To contact the editor responsible for this story:

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business